Recently, it was reported that BTK inhibitors exerted potential beneficial effects against numerous types of solid tumour, including glioblastoma multiforme and breast cancer; however, whether BTK is crucial for the progression of bladder cancer remains unclear [111]. The gene discussed is BTK; the disease is urinary bladder carcinoma.